Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in Advanced Chronic Heart Failure
NCT01290146Phase 3Terminated
- Sponsor
- ASST Grande Ospedale Metropolitano Niguarda
- Start
- Feb 2011
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levosimendan in chronic heart failure (CHF), sponsored by ASST Grande Ospedale Metropolitano Niguarda. Started Feb 2011; status: terminated.
02
Drugs
levosimendan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT01290146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01290146.